Public Company

Cipla to raise Rs 1,500 cr by issue of shares

Drug maker Cipla today said it will raise Rs 1,500 crore from international market by issue of securities. - SC refuses relief to Roche on patent plea against Cipla - Drug to treat swine flu to be available in retail mkt - JB Chemicals gets USFDA nod for its anti-allergic tablets - Cipla gains 3% on capex plan - GSK to launch "promecta" in India by 2009-end - Aurobindo Pharma receives Swissmedic approval for cefepime for injection The shareholders have approved raising Rs 1,500 crore by issuing non-convertible debentures, Foreign Currency Convertible Bonds, American Depository Receipts and Global Depository Receipts, Cipla said in a filing to the Bombay Stock Exchange. The proposal is subjected to necessary regulatory approvals, the filing added. Shares of Cipla today closed at Rs 272.30 on BSE, up 0.91 per cent from the previous close.

Add your comment:

Name:
Site address:	http://
Your message:
Enter today\\\\'s date, 2 digits (spam protection):